Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Long-Term Debt Issuances (2020)

Historic Long-Term Debt Issuances for Aclaris Therapeutics (ACRS) over the last 1 years, with Q2 2020 value amounting to -$37000.0.

  • Aclaris Therapeutics' Long-Term Debt Issuances changed N/A to -$37000.0 in Q2 2020 from the same period last year, while for Dec 2020 it was $10.9 million, marking a year-over-year change of. This contributed to the annual value of $10.9 million for FY2020, which is N/A changed from last year.
  • Aclaris Therapeutics' Long-Term Debt Issuances amounted to -$37000.0 in Q2 2020.
  • In the past 5 years, Aclaris Therapeutics' Long-Term Debt Issuances registered a high of $11.0 million during Q1 2020, and its lowest value of -$37000.0 during Q2 2020.